Chronic Fatigue Syndrome (ME/CFS) Treatment with Stem Cells
- Written by
- StemCell Longevita Editorial Team
- Medically reviewed by
- Prof. Dr. Erdal Karaöz TeamProfessor of Histology and Embryology · Medical Director, Center for Regenerative Medicine
- Last reviewed
- Next scheduled review
How we evaluate evidence · Conflict-of-interest disclosure · Editorial standards
Advanced mesenchymal regenerative medicine approach to address mitochondrial dysfunction, reduce systemic inflammation, and restore energy in ME/CFS patients.
Can stem cell therapy help chronic fatigue syndrome or ME/CFS?
Mesenchymal stem cell therapy is not an approved treatment for chronic fatigue syndrome or myalgic encephalomyelitis. There are no controlled trials showing a consistent, clinically meaningful benefit in this population. Established care — pacing, sleep and pain management, and treatment of any identifiable comorbidities — remains the evidence-based path under specialist guidance. Regenerative options here are considered only alongside such a plan, not as replacement.
Key facts
- Approval status
- Not approved for ME/CFS
- Evidence
- No controlled trials showing benefit in this population
- Standard care
- Pacing, sleep and pain management, comorbidity treatment
What we know
- Pacing (energy management) has expert-consensus support in ME/CFS while research on disease-modifying therapy continues.
What remains uncertain
- Whether any regenerative modality has a plausible mechanism relevant to ME/CFS pathophysiology.
Medically reviewed questions
This summary is general medical information, not medical advice, and not a promise of benefit. Figures are quoted ranges, confirmed in writing after a medical review.
Medically reviewed by: Prof. Dr. Erdal Karaöz · Last updated: · Editorial and evidence policy
Evidence at a glance — Chronic fatigue syndrome (ME/CFS)
A plain summary of what the published research does and does not show for this condition. It is written to the same standard whether the evidence is strong or weak.
- Human studies available?
- Limited
- Randomised trials?
- None identified
- Main outcomes studied
- Fatigue severity scales
- Function
- Quality of life
- Long-term evidence
- Very limited
- Regulatory approval for this indication
- United States (FDA): No FDA-approved mesenchymal stem cell product for this indication. The FDA has issued consumer warnings about unapproved stem cell products.
- European Union (EMA): No EMA-authorised mesenchymal stem cell medicine for this indication.
- United Kingdom (MHRA): No MHRA-authorised mesenchymal stem cell medicine for this indication.
- Türkiye (Ministry of Health): In Türkiye, cell therapies are delivered only inside Ministry of Health–licensed centres under the regenerative medicine / advanced therapy regulations, as clinical research or individual (exceptional) use — not as an approved routine treatment for this indication.
- Role at our centre
- Research context — considered only where standard care is exhausted or unsuitable, and never as a replacement for it
What kind of evidence exists
- Mechanism (laboratory): Documented
- Animal / preclinical: Documented
- Early human (phase 1/2, uncontrolled): Documented
- Controlled human (randomised or sham-controlled): Not established
- Regulatory approval: Not established
Sources
- Systematic reviews and meta-analyses — Chronic fatigue syndrome (ME/CFS) — PubMed
- Randomised controlled trials — Chronic fatigue syndrome (ME/CFS) — PubMed
- Registered MSC trials — Chronic fatigue syndrome (ME/CFS) — ClinicalTrials.gov
- FDA — Consumer alert on regenerative medicine therapies — U.S. Food and Drug Administration, 2024
- Advanced therapy medicinal products: overview — European Medicines Agency, 2025
- ISSCR Guidelines for Stem Cell Research and Clinical Translation — International Society for Stem Cell Research, 2021
- ISSCR Patient Handbook on Stem Cell Therapies — International Society for Stem Cell Research, 2020
Source links open filtered searches of PubMed and ClinicalTrials.gov plus regulator and professional-society pages, so you can read the current evidence yourself rather than a selected extract.
This summary is general information about the evidence base, not medical advice and not a promise of benefit. Whether any treatment is appropriate for you can only be decided after a medical review of your records.
What Is Chronic Fatigue Syndrome (ME/CFS)?
Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME), is a complex, debilitating condition characterized by profound fatigue that is not improved by rest and worsens with physical or mental exertion (post-exertional malaise). It affects an estimated 17-24 million people worldwide.
ME/CFS involves dysfunction across multiple body systems: immune dysregulation, mitochondrial impairment, neuroinflammation, autonomic nervous system dysfunction, and hormonal imbalances. Patients often experience brain fog, unrefreshing sleep, muscle and joint pain, headaches, and orthostatic intolerance.
Mesenchymal stem cell therapy addresses ME/CFS by targeting its core pathological mechanisms: MSCs reduce systemic inflammation, support mitochondrial repair, modulate the dysregulated immune system, and provide neuroprotective effects — offering a comprehensive regenerative approach to this multi-system condition.
Benefits of Stem Cell Therapy for ME/CFS
MSC therapy addresses the multi-system dysfunction underlying chronic fatigue syndrome through powerful regenerative and immunomodulatory mechanisms.
Deep Fatigue Relief
MSCs target the core exhaustion of ME/CFS by reducing systemic inflammation and supporting cellular repair, helping patients regain functional energy levels.
Immune System Rebalancing
MSCs modulate the dysregulated immune response characteristic of ME/CFS, reducing chronic immune activation and restoring normal immune surveillance and function.
Energy & Mitochondrial Support
MSCs transfer healthy mitochondria to damaged cells and secrete factors that improve mitochondrial biogenesis, directly addressing the cellular energy crisis at the heart of ME/CFS.
Sleep & Autonomic Improvement
As neuroinflammation decreases and autonomic function stabilizes, many patients experience significantly improved sleep quality, energy levels, and refreshment upon waking.
Pain & Inflammation Relief
MSCs' anti-inflammatory properties help reduce the widespread muscle and joint pain, headaches, and general malaise experienced by ME/CFS patients.
Neuroinflammation Reduction
By crossing the blood-brain barrier, MSCs and exosomes reduce the neuroinflammation that contributes to brain fog, cognitive dysfunction, and unrefreshing sleep.
Patient Experiences
Real outcomes from patients who chose regenerative medicine at StemCell Longevita Istanbul
"My hepatologist said the liver scan improvement was remarkable. I was preparing for the worst — now I'm planning for the future."
"I flew to Istanbul sceptical. Six months later, my endocrinologist at home took me off insulin. The numbers speak for themselves."
Your ME/CFS Recovery Process
Our comprehensive protocol targets the multi-system dysfunction of chronic fatigue syndrome through personalized regenerative medicine.
Comprehensive Evaluation
Detailed assessment including immune panels, mitochondrial function markers, inflammatory markers, autonomic function testing, and quality of life scoring.
Personalized Protocol
Based on your specific symptom profile and test results, our specialists design an individualized MSC and exosome treatment protocol.
Cell Preparation
Wharton's jelly MSCs prepared in our GMP-certified laboratory with 97% cell viability guarantee and comprehensive quality documentation.
Treatment Administration
IV infusion of high-dose MSCs combined with exosome therapy for enhanced cellular repair. Optional intrathecal delivery for prominent neurological symptoms.
Recovery & Monitoring
Structured follow-up at 1, 3, and 6 months with biomarker tracking, fatigue severity scoring, and protocol optimization guidance.
Frequently Asked Questions About ME/CFS Treatment
Find answers to the most common questions about stem cell therapy for Chronic Fatigue Syndrome.
All Regenerative Medicine Applications
Explore our comprehensive range of regenerative medicine applications for various conditions. Click any option to learn more.
Related Treatments
Related Articles
Explore our in-depth research articles and guides on related treatments and therapies.
Regenerative Medicine for Liver Disease: Support & Progress
How mesenchymal stem cell approaches may support liver health in cases of cirrhosis, fatty liver, and fibrosis, promoting tissue support and hepatic function.
Read ArticleManaging Diabetes with Regenerative Medicine
Explore the role of regenerative medicine in diabetes management, including potential benefits for insulin production and blood sugar regulation through cellular regeneration.
Read ArticleUnderstanding Regenerative Medicine: A Complete Guide
A comprehensive overview of stem cell therapy, including types of stem cells, care processes, safety considerations, and what patients can expect during their wellness journey.
Read ArticleRelated clinical questions
Where this page sits in the wider picture.